Comparison of the Efficacy and Acceptability of Isosorbide 5-Mononitrate, Isosorbide Dinitrate and Propranolol in the Management of Angina Pectoris
Although isosorbide 5-mononitrate (IS-5-MN) has theoretical advantages over isosorbide dinitrate (ISDN) in terms of metabolism and bioavailability [1–3] there is no conclusive evidence to show that these are reflected in improved therapeutic benefit in clinical practice. A study has therefore been undertaken to compare the efficacy and acceptability of IS-5-MN, ISDN and the beta-adrenoreceptor antagonist propranolol (PROP) in the management of 20 patients with angina pectoris. This is an interim report.
KeywordsAngina Pectoris Intermittent Claudication Interim Report Isosorbide Dinitrate Anginal Attack
Unable to display preview. Download preview PDF.
- 2.Abshagen U, Sporl-Radnn S (1980) Pharmacokinetics and effect of 5-isosorbide mononitrate (5IS-5-MN) in normal man. In: World conference on clinical pharmacology and therapeutics. MacMillan, London, p.0377Google Scholar